PREVIEW · SERVICE NOT YET OPENExplore Script · Assessments are not open yet

Clinically led. Care made personal.

MEDICINE & ASSESSMENT GUIDE

Understanding aciclovir

Aciclovir tablet

Draft patient information · awaiting clinical review.

A starting point for your conversation

This guide relates to an aciclovir assessment for genital herpes. A first episode, a recurrence and ongoing preventive treatment need different clinical consideration.

This is information about preparing for care. It does not establish whether a medicine is suitable for you or replace advice from your clinician.

What to discuss

Include anything that has changed since a previous assessment. It is fine to say when you do not know an answer.

  • Previous diagnosis, test results and the current symptoms
  • Frequency of episodes and treatments already used
  • Kidney health, pregnancy where relevant and other medicines

Your GP or usual prescriber’s details and your preferences about sharing care information form part of the assessment.

What to have ready

Your current medicines and allergies

Include prescribed medicines, anything bought elsewhere and any reactions you have had.

What you have tried already

Have the treatment names and details of how they worked, including any side effects.

Your GP or usual prescriber’s details

The assessment asks who usually looks after your health and about contact with them.

What a review can lead to

A clinician may need further information, an examination, records or test results. The outcome may be advice, non-medicine options, a different treatment, a prescription where appropriate, or referral for other care.

Ask about expected benefits, possible side effects, interactions, alternatives and when treatment should be reviewed. An assessment or a previous prescription does not guarantee further prescribing.

Further reading

These primary sources provide additional information. Product information may relate to a specific brand or formulation; always check the leaflet supplied with your own medicine.

Clinical sign-off is pending. This preview is not a prescribing or dosing guide.